Treatments for postmenopausal osteoporosis are generally safe, but are linked to some rare
serious adverse drug reactions, for which causality is not always certain. The …

BACKGROUND: Bisphosphonates are used to fight osteoporosis and for treating
malignancies. In 2003, the first case reports appeared that described bisphosphonate …

Corticosteroids have been used in ophthalmology for almost 50 years. Hench, in 1949, 1
was the first to report on the beneficial eVects of ACTH and cortisone. His work was with …

OBJECTIVE: To provide a review of current developments in bisphosphonates indicated for
the treatment of several rheumatologic conditions, including postmenopausal and …

Background Topical preparations, high in phosphate, may cause calcification when used on
a damaged corneal surface. The knowledge of the phosphate concentration in medications …

Background Intravenous bisphosphonates are widely used for treatment of postmenopausal
osteoporosis. They are associated with transient influenza-like symptoms, predominantly …

SIR, Atypical femoral fractures (AFFs) of the skeleton and osteonecrosis of the jaw (ONJ) are
known adverse reactions to bisphosphonates. Among the orally administered …

This article reviews several retrospective case series and reported adverse events regarding
common ocular adverse effects related to systemic therapy. It is not intended as a …

Objective: To assess the incidence of uveitis associated with topical β-blockers. Design:
Retrospective cohort study. Setting: A computerized database of a health maintenance …

Use of bisphosphonates has been growing steadily in the last decade. This follows the
introduction of simpler dosing regimes, the availability of lower-priced generics, and …